13F-HR filed by Healthcare Value Capital, LLC
Healthcare Value Capital, LLC filed this 13F-HR for the quarter ended 2021-09-30, filed 2021-11-15, with 25 holding rows worth $50,652,000.
- Accession
- 0000919574-21-006956
- Filer
- CIK 1458461
- Filed
- 2021-11-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2021
A holdings report, 25 entries on the cover page, a total value of $50,652,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $50,654,000 with VALUE read as thousands by filing date, 13F file number 028-14998. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| Gilead Sciences,Inc. | 375558103 | COM | 60,000 | $4,191,000 | thousands by filing date | |
| GLAXOSMITHKLINE PLC-ADR | 37733W105 | SPONSORED ADR | 100,000 | $3,821,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 75,000 | $3,226,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 100,000 | $3,084,000 | thousands by filing date | |
| ALKERMES PLC | G01767105 | SHS | 100,000 | $3,084,000 | thousands by filing date | put |
| AMRYT PHARMA LTD - SPNR ADR | 03217L106 | COMMON EQUITY | 250,000 | $3,023,000 | thousands by filing date | |
| Merck & Co.,Inc. | 58933Y105 | COM | 40,000 | $3,004,000 | thousands by filing date | |
| ASTRAZENECA PLC SPONSORED ADR | 046353108 | ADR | 50,000 | $3,003,000 | thousands by filing date | |
| Bristol-Myers Squibb Company | 110122108 | COM | 50,000 | $2,959,000 | thousands by filing date | |
| ProShares UltraPro Short S&P 500 | 74347B110 | COM | 150,000 | $2,631,000 | thousands by filing date | call |
| IRONWOOD PHARMACEUTICALS INC | 46333X108 | COMMON STOCK | 200,000 | $2,612,000 | thousands by filing date | |
| CLOVIS ONCOLOGY INC | 189464100 | COM | 500,000 | $2,230,000 | thousands by filing date | |
| Pfizer Inc. | 717081103 | COM | 50,000 | $2,151,000 | thousands by filing date | put |
| TYME TECHNOLOGIES INC COM | 90238J103 | Stock | 2,000,000 | $2,060,000 | thousands by filing date | |
| ANTARES PHARMA INC | 036642106 | COM | 500,000 | $1,820,000 | thousands by filing date | |
| PROSHARES TR | 74347G861 | ULTRAPRO SHT QQQ | 200,000 | $1,726,000 | thousands by filing date | call |
| PROSHARES | 74347Y839 | EXCHANGE TRADED | 50,000 | $1,228,000 | thousands by filing date | call |
| AMARIN CORP PLC | 023111206 | SPONS ADR NEW | 200,000 | $1,020,000 | thousands by filing date | call |
| Vertex Pharmaceuticals Incorporated | 92532F100 | COM | 5,000 | $907,000 | thousands by filing date | |
| GREENLANE HLDGS INC | 395330103 | CL A | 350,000 | $830,000 | thousands by filing date | |
| VYNE THERAP. | 92941V209 | COM | 400,000 | $556,000 | thousands by filing date | |
| ADAMAS PHARMACEUTICALS INC | 00548A106 | COM | 100,000 | $491,000 | thousands by filing date | |
| GAMIDA CELL LTD | M47364100 | SHS | 100,000 | $392,000 | thousands by filing date | |
| DURECT CORP | 266605104 | COM | 250,000 | $320,000 | thousands by filing date | |
| PROSHARES TR II | 74347Y854 | FUND | 12,500 | $285,000 | thousands by filing date | call |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0000919574-21-006956 | this filing | 2021-11-15 | acceptance time not in the bulk data set |